Nordmark Arzneimittel GmbH & Co. KG   Report issue

For profit Phase 2
Founded: Uetersen Germany (2001)

Organization Overview

First Clinical Trial
2012
NCT03076411
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now